MML Investors Services’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $302K | Buy |
4,615
+1,328
| +40% | +$86.9K | ﹤0.01% | 2425 |
|
|
2025
Q1 | $232K | Buy |
3,287
+230
| +8% | +$16.2K | ﹤0.01% | 2456 |
|
|
2024
Q4 | $201K | Sell |
3,057
-48
| -2% | -$3.16K | ﹤0.01% | 2521 |
|
|
2024
Q3 | $219K | Sell |
3,105
-136
| -4% | -$9.59K | ﹤0.01% | 2385 |
|
|
2024
Q2 | $215K | Buy |
3,241
+248
| +8% | +$16.5K | ﹤0.01% | 2306 |
|
|
2024
Q1 | $203K | Buy |
+2,993
| New | +$203K | ﹤0.01% | 2352 |
|
|
2023
Q2 | – | Sell |
-3,615
| Closed | -$211K | – | 2320 |
|
|
2023
Q1 | $211K | Buy |
+3,615
| New | +$211K | ﹤0.01% | 1883 |
|
|
2022
Q3 | – | Sell |
-3,300
| Closed | -$211K | – | 2111 |
|
|
2022
Q2 | $211K | Sell |
3,300
-12
| -0.4% | -$767 | ﹤0.01% | 1875 |
|
|
2022
Q1 | $214K | Sell |
3,312
-45
| -1% | -$2.91K | ﹤0.01% | 1922 |
|
|
2021
Q4 | $223K | Sell |
3,357
-276
| -8% | -$18.3K | ﹤0.01% | 1867 |
|
|
2021
Q3 | $222K | Buy |
3,633
+48
| +1% | +$2.93K | ﹤0.01% | 1818 |
|
|
2021
Q2 | $222K | Buy |
3,585
+72
| +2% | +$4.46K | ﹤0.01% | 1775 |
|
|
2021
Q1 | $208K | Buy |
3,513
+60
| +2% | +$3.55K | ﹤0.01% | 1711 |
|
|
2020
Q4 | $206K | Buy |
+3,453
| New | +$206K | ﹤0.01% | 1584 |
|
|
2019
Q1 | – | Sell |
-5,697
| Closed | -$267K | – | 1614 |
|
|
2018
Q4 | $267K | Sell |
5,697
-2,253
| -28% | -$106K | ﹤0.01% | 1224 |
|
|
2018
Q3 | $445K | Buy |
7,950
+3,405
| +75% | +$191K | 0.01% | 1056 |
|
|
2018
Q2 | $229K | Sell |
4,545
-4,104
| -47% | -$207K | 0.01% | 1205 |
|
|
2018
Q1 | $425K | Sell |
8,649
-10,209
| -54% | -$502K | 0.01% | 910 |
|
|
2017
Q4 | $970K | Sell |
18,858
-53,391
| -74% | -$2.75M | 0.02% | 557 |
|
|
2017
Q3 | $3.77M | Sell |
72,249
-32,403
| -31% | -$1.69M | 0.08% | 214 |
|
|
2017
Q2 | $5.41M | Buy |
+104,652
| New | +$5.41M | 0.1% | 168 |
|